| ²é¿´: 474 | »Ø¸´: 5 | |||
| ±¾Ìû²úÉú 1 ¸ö ²©Ñ§EPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
ÎÒÊÇÎÒ2082Ö÷¹ÜÇø³¤
|
[½»Á÷]
ÇóÖúÁ½ÆªÎÄÏ×£¬Ð»Ð»
|
||
|
1£¬ÎÄÌ⣺aromatase inhibitors:Rationale and use in breast cancer. ×÷ÕߣºC Osborne, D Tripathy ÆÚ¿¯£ºAnnual Review of Medicine 2£¬±êÌâ: Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers ×÷Õß: VANASWEGEN, CH; PURDY, RH; WITTLIFF, JL À´Ô´³ö°æÎï: JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY ¾í: 32 ÆÚ: 4 Ò³: 485-492 |
» ²ÂÄãϲ»¶
²ÄÁϵ÷¼Á
ÒѾÓÐ11È˻ظ´
295²ÄÁϹ¤³Ìר˶Çóµ÷¼Á
ÒѾÓÐ18È˻ظ´
081200-11408-276ѧ˶Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ10È˻ظ´
²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
²ÄÁÏר˶322·Ö
ÒѾÓÐ10È˻ظ´
311Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
0856£¬269·ÖÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸ ÄϾ©Óʵç´óѧ 288·Ö ²ÄÁÏ¿¼ÑÐ Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
085602»¯Ñ§¹¤³Ì268·Ö¶×µ÷¼Á
ÒѾÓÐ8È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
¼±ÇóÖúÁ½ÆªÎÄÏ×£¬Ð»Ð»
ÒѾÓÐ2È˻ظ´
ÇóÖúÁ½ÆªÎÄÏ×£¬¼±Óã¬ÓÐÁ´½Ó£¬Ð»Ð»~~~
ÒѾÓÐ2È˻ظ´
ÇóÖúÁ½ÆªÎÄÏ×£¬Ð»Ð»¡£
ÒѾÓÐ0È˻ظ´
¡¾ÇóÖú¡¿¸÷λ´ïÈË£¬ÇóÖúÁ½ÆªÎÄÏ×£¬¼±Ðè
ÒѾÓÐ0È˻ظ´
¡¾ÇóÖú¡¿ÇóÖúÁ½ÆªÎÄÏ×£¬¼±Ð裬°ï棬лл
ÒѾÓÐ6È˻ظ´
ÎÒÊÇÎÒ2082
¶Ò»»¹ó±ö
![]()
![]()
![]()
![]()
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 9615
- É¢½ð: 20
- ºì»¨: 1
- Ìû×Ó: 3490
- ÔÚÏß: 289.3Сʱ
- ³æºÅ: 639736
- ×¢²á: 2008-10-29
- ÐÔ±ð: GG
- רҵ: ϸ°ûÉúÎïѧÑо¿ÖеÄз½·¨
6Â¥2010-07-25 14:11:08
yujian8608
¶Ò»»¹ó±ö
ƽ³£ÐÄ£¬Æ½³£ÐÄ£¡
![]()
![]()
![]()
![]()
- ²©Ñ§EPI: 50
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 0.1
- ½ð±Ò: 2799.7
- É¢½ð: 1732
- ºì»¨: 10
- Ìû×Ó: 3935
- ÔÚÏß: 132.8Сʱ
- ³æºÅ: 560167
- ×¢²á: 2008-05-18
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ

2Â¥2010-07-24 23:29:08
ÎÒÊÇÎÒ2082
ʵϰ°æÖ÷
![]()
![]()
![]()
![]()
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 9615
- É¢½ð: 20
- ºì»¨: 1
- Ìû×Ó: 3490
- ÔÚÏß: 289.3Сʱ
- ³æºÅ: 639736
- ×¢²á: 2008-10-29
- ÐÔ±ð: GG
- רҵ: ϸ°ûÉúÎïѧÑо¿ÖеÄз½·¨
3Â¥2010-07-25 10:23:54
µ²²»×¡µÄºÃÔË
Ö÷¹ÜÇø³¤
![]()
![]()
![]()
![]()
- ²©Ñ§EPI: 1
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 46.5
- É¢½ð: 5
- ºì»¨: 1
- Ìû×Ó: 435
- ÔÚÏß: 67.6Сʱ
- ³æºÅ: 401075
- ×¢²á: 2007-06-13
- רҵ: ÖÆÔìϵͳÓë×Ô¶¯»¯
4Â¥2010-07-25 10:26:15














»Ø¸´´ËÂ¥